The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
September 2023
Volume 19 Number 7
This month we bring you a State-of-the-Art on cerebral embolic protection during transcatheter heart interventions and a debate on the pros and cons of guided DAPT. In coronary interventions: the 3-year outcomes of the EuroCTO trial comparing the long-term safety of percutaneous coronary intervention (PCI) for chronic total occlusions as compared with optimal medical therapy (OMT); In interventions for valvular disease and heart failure: the feasibility and safety of the novel balloon-expandable Myval device for treating non-calcified aortic regurgitation; from the REVASC TAVI registry, a study concerning the timing of PCI in treating patients with severe aortic stenosis who received PCI either before, after or concomitantly with transcatheter aortic valve implantation (TAVI). In interventions for hypertension and stroke: an article on alcohol-mediated renal denervation (RDN); a histological examination of the distribution of renal nerves in order to optimise RDN, focusing on the post-bifurcation vessel segments; and more.